Antibiotic TS 155-2 (CAS 303009-07-6)

Antibiotic TS 155-2, a promising antimicrobial compound, has been a subject of significant scientific investigation owing to its unique mechanism of action and potential applications in microbiology and drug discovery. Mechanistically, TS 155-2 targets bacterial RNA polymerase, a fundamental enzyme responsible for transcribing DNA into RNA during gene expression. By binding to the active site of RNA polymerase, TS 155-2 disrupts its catalytic activity, leading to inhibition of RNA synthesis and subsequent impairment of bacterial growth and viability. This mechanism distinguishes TS 155-2 from conventional antibiotics, offering promise for combating multidrug-resistant bacterial pathogens. In research, TS 155-2 has been instrumental in elucidating the structural and functional properties of bacterial RNA polymerase, providing insights into the molecular basis of antibacterial activity and bacterial resistance mechanisms. Moreover, its broad-spectrum activity against a wide range of bacterial species, including relevant pathogens such as Escherichia coli and Pseudomonas aeruginosa, underscores its potential as a valuable tool for studying bacterial physiology, pathogenesis, and antimicrobial resistance. Additionally, TS 155-2′s structural diversity and synthetic accessibility have positioned it as a lead compound in antibiotic discovery programs, driving efforts to develop novel antibacterial agents with improved potency, selectivity, and pharmacokinetic properties. Ongoing research endeavors continue to explore the potential of TS 155-2 and its derivatives, paving the way for innovative strategies to combat infectious diseases and address the global challenge of antibiotic resistance.